Status:
RECRUITING
Multicenter Registry on Robotically Assisted PCI - TESLA
Lead Sponsor:
Clinical Research Center, Intercard Sp. z o.o.
Collaborating Sponsors:
Corindus, Inc. dba Siemens Healthineers Endovascular Robotics
KCRI Sp. z o.o.
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
MulTicenter rEgiStry on RoboticalLy Assisted percutaneous coronary interventions- TESLA registry is a retrospective registry evaluating the safety and efficacy of robotically assisted PCI with the Cor...
Detailed Description
R-PCI represents a novel approach to performing PCI with several studies showing high technical success and low complication rates. The CorPath GRX System is the second generation of the CorPath platf...
Eligibility Criteria
Inclusion Criteria:
- Older than 18 years,
- Patients with either stable coronary artery disease, unstable angina, or acute myocardial infarction (MI),
- Coronary artery lesions considered suitable for R-PCI with CorPath GRX System.
Exclusion Criteria:
- Unwillingness to provide informed consent (only if applicable).
Key Trial Info
Start Date :
March 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT05841745
Start Date
March 1 2023
End Date
July 1 2024
Last Update
July 11 2024
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Hartcentrum OLV Aalst
Aalst, Belgium
2
SEGEBERGER Kliniken GmbH
Bad Segeberg, Germany
3
Universitätsklinikum Freiburg
Freiburg im Breisgau, Germany
4
Sapporo Cardiovascular Clinic
Sapporo, Japan